UK AI Mega-Rounds Capture Europe’s H1 2026 Funding Rebound

European tech raised €44.1 billion in the first half of 2026 across just over 1,740 deals. Funding recovered from the sharp 2025 drop even as transaction volume kept falling, locking more capital into fewer companies.

Tech.eu’s mid-year tally shows the pattern in plain numbers. The winners sit in the UK and in capital-intensive AI, cloud and deeptech. Everyone else is working a thinner market.

Capital Climbed While Deal Count Slipped

H1 2024 still holds the recent peak at €50.1 billion across roughly 2,000 deals. H1 2025 then saw funding fall more than 30 percent year-on-year while deal activity held roughly steady. Investors had already grown selective.

H1 2026 reversed the funding decline but not the deal decline. Capital reached €44.1 billion. Deals dropped to just over 1,740. Average cheque size rose as money funnelled into larger rounds.

• €44.1 billion total H1 2026 funding
• ~1,740 deals, down from ~2,000 in H1 2024
• Over 6,410 investors participated
• HTGF led activity with 31 deals

The divergence is the story. Capital is available. Breadth is not.

UK Took the Lion’s Share of Mega Rounds

The United Kingdom dominated both total capital and the largest individual financings. UK companies raised €18.7 billion across 423 deals, more than three times Germany’s €6.3 billion. France followed at €6.0 billion from only 132 deals. Sweden (€2.8 billion), the Netherlands (€1.9 billion) and Spain (€1.7 billion) completed the top tier.

Six of the ten biggest transactions exceeded €1 billion and six of those ten were UK-based. Pure Data Centres led with a €2.3 billion debt financing, matching its broader $2.7 billion data centre financing package for AI infrastructure across Europe and the Middle East. Isomorphic Labs followed with an €1.8 billion Series B (the company announced a $2.1 billion Series B led by Thrive Capital with Alphabet, GV, MGX, Temasek, CapitalG and the UK Sovereign AI Fund). Germany supplied two of the top ten; Sweden and France one each.

Silverpeak’s growth-stage cut shows the same UK skew: the country took 56 percent of Series B and C capital in the half, lifted by Nscale’s record €2.9 billion Series C and Isomorphic’s Series B. Strip those two out and the UK share falls back toward its long-run average near 29 percent. The mega-rounds, not a broad base, drove the lead.

AI, Fintech and Healthtech Absorbed Nearly €15 Billion

Artificial intelligence led all verticals with €5.9 billion, powered by those mega-rounds. Fintech drew €4.7 billion and healthtech €4.3 billion. Together the three sectors took nearly €15 billion. Software posted the highest deal count at 338, showing continued appetite for enterprise and AI-enabled applications even when pure funding dollars chased fewer names.

Cloud infrastructure, robotics and other capital-heavy categories filled out the largest individual tickets. Deeptech overall reached a period high in Silverpeak’s Series B/C data at €7.7 billion, more than 60 percent of that growth capital for a second straight half. Life sciences jumped on Isomorphic. Robotics, drones and quantum also climbed.

KPMG’s Q2 pulse captured the same filter: investors preferred AI-native companies over software firms simply adding AI features. Defensetech moved from fringe to mainstream on geopolitical pressure and dual-use demand, a theme that also shows up in the European defense fund anchored by Airbus.

The Mid-Market Stayed Flat While the Top End Surged

Silverpeak tracked Series B and C capital at €12.3 billion in H1 2026, the strongest half since 2022. Series C more than doubled half-on-half to €7.1 billion (+447 percent year-on-year). Series B rose a steadier 15 percent to €5.3 billion. Total growth-stage deal count was only 106, still down 17 percent year-on-year.

Concentration hit a high: the five largest deals took 55% of capital. That share more than doubled the roughly 20 percent common in 2021-22. Beneath the megas, the core sub-€100 million market stayed stuck between €3.0 billion and €3.7 billion per half for four years. At 88 deals it was the thinnest first half in the period Silverpeak shows.

What the numbers show

• 85 percent of the 575 companies that raised a first Series B in 2021-23 still have not raised a Series C, representing €18.5 billion of earlier capital.
• Median Series C pre-money hit a five-year high of €814 million; Series B eased to €111 million.
• Dilution stayed low (15 percent at C, 18 percent at B) for the companies that cleared the bar.
• 2024-25 graduates reached Series C in a median 14 months; the fastest did it in roughly six.

The funnel narrowed rather than lengthened. Category leaders raise larger rounds faster at founder-friendly dilution. The large stalled cohort faces a longer wait or a sale. That is the zero-sum inside the headline rebound.

I don’t see AI investment going away anytime soon. What we’re seeing now is that the really strong AI native businesses are the ones getting the money, while the ones that were just associating themselves with AI are now falling away.

Nicole Lowe, UK Head of Emerging Giants at KPMG in the UK, put the filter in plain language. The same selectivity shows up in live conversation: UK commentator Seb Johnson noted nearly half of European venture flowing into the UK early in the year on the back of Isomorphic, Nscale, Wayve and others, arguing the gap may widen rather than close. Crowd tallies counted nine European companies that raised $1 billion-plus rounds in 2026 so far. The list is real. The breadth is not.

How This Half Compares with Earlier Peaks

Crunchbase data put European H1 2026 startup funding around $42 billion, up roughly 50 percent year-on-year yet still well below the 2021 H1 peak near $60 billion. Tech.eu’s euro figures show the same shape: H1 2024’s €50.1 billion remains the recent high-water mark; 2025 was the correction; 2026 is a partial, concentrated recovery.

Growth-stage capital is now back near post-2022 strength, but only because a handful of outsized rounds lifted the total. Exit conditions stayed muted. KPMG noted M&A still supplied most liquidity while IPOs lagged. US buyers continued to look at UK assets on valuation grounds. Capital efficiency and clear paths to scale remain the price of admission.

The pattern also echoes the why-now test sorting the H1 boom that investors applied across the wider startup market. Timing and strategic fit now decide who gets the large cheque.

Founders Face a Sharper Split in What Comes Next

For companies already recognised as category leaders in AI infrastructure, drug design, robotics or dual-use tech, capital is deep and dilution remains manageable. They can raise at speed and keep control. For everyone else the bar has risen.

Practical implications land differently by stage:

• Early and seed rounds still occur, but follow-on conviction is scarcer outside the hot verticals.
• Growth-stage founders without clear category leadership should plan for longer runways or M&A paths rather than automatic Series C.
• Geographic concentration means talent and later capital continue to cluster in London and a few other hubs; secondary ecosystems need stronger local anchors or cross-border strategies.
• AI-native positioning is no longer optional marketing. Investors are sorting hard between core AI and AI-adjacent.

Some European AI companies still run core infrastructure on non-European clouds, a dependency visible in cases such as the European AI push on American cloud. That infrastructure layer is itself drawing large capital, which further concentrates the winners.

Silverpeak’s reading is direct: conviction capital is back for proven leaders; selectivity remains the rule for the rest. KPMG expects AI and defensetech to stay the strongest themes into the next quarter, alongside biotech and alternative energy. The muted exit environment will keep pressure on profitability metrics.

H1 2026 delivered a real rebound in euros deployed. It also delivered a clearer map of who receives them. UK AI and deeptech mega-rounds took the gains. The mid-market and most smaller ecosystems absorbed the cost in lower deal volume and higher bars. That split, not the headline total, is what founders and LPs will underwrite against for the rest of the year.

Frequently Asked Questions

How much did European tech raise in H1 2026 compared with prior years?

Tech.eu recorded €44.1 billion in H1 2026. That sits below H1 2024’s €50.1 billion peak but well above the sharp drop of H1 2025, when funding fell more than 30 percent year-on-year. Deal count continued downward to just over 1,740 from roughly 2,000 in the 2024 half.

Which country raised the most European tech capital in H1 2026?

The United Kingdom led with €18.7 billion across 423 deals, more than triple Germany’s €6.3 billion. France raised €6.0 billion from 132 deals. The UK also supplied six of the ten largest individual rounds.

What were the largest individual European tech rounds in H1 2026?

Pure Data Centres’ €2.3 billion debt financing and Isomorphic Labs’ €1.8 billion Series B (announced as $2.1 billion) topped the list. Six of the top ten exceeded €1 billion and sat mainly in cloud infrastructure, AI and robotics. Nscale’s €2.9 billion Series C was the largest disclosed European Series C on Silverpeak’s growth-stage record.

Which sectors attracted the most funding in European tech H1 2026?

Artificial intelligence led with €5.9 billion, followed by fintech at €4.7 billion and healthtech at €4.3 billion. The three together drew nearly €15 billion. Software recorded the most deals at 338 even if pure capital dollars favoured the mega AI and infrastructure names.

How concentrated was growth-stage capital in H1 2026?

In Silverpeak’s Series B and C data the five largest deals absorbed 55 percent of capital invested, more than double the roughly 20 percent share typical in 2021-22. The sub-€100 million core market stayed flat in both volume and capital for four consecutive years while the top end set records.